Advanced Filters
noise

Rionero in Vulture, Italy Clinical Trials

A listing of Rionero in Vulture, Italy clinical trials actively recruiting patients volunteers.

Found 6 clinical trials

Study of Sacituzumab Govitecan Versus Treatment of Physician's Choice in Patients With Hormone Receptor-positive/Human Epidermal Growth Factor Receptor 2 Negative (HR+/HER2-) Metastatic Breast Cancer Who Have Received Endocrine Therapy

The goal of this clinical study is to see if sacituzumab govitecan-hziy (SG) can improve life spans of people with HR+/HER2- metastatic breast cancer and their tumor does not grow or spread when compared to currently available standard treatments, such as paclitaxel, nab-paclitaxel or capecitabine. The primary objective is to …

18 - 100 years of age Both Phase 3

Clinical Trial of Lurbinectedin as Single-agent or in Combination With Irinotecan Versus Topotecan or Irinotecan in Patients With Relapsed Small-cell Lung Cancer (LAGOON)

Multicenter, open-label, randomized, controlled phase III clinical trial to evaluate and compare the activity and safety of two experimental arms consisting of lurbinectedin as single agent (Group A) or the combination of lurbinectedin with irinotecan (Group B) versus Investigator's Choice (topotecan or irinotecan) as control arm (Group C), in Small-cell …

18 - 100 years of age Both Phase 3
K Keri Maher, DO

Study of Selinexor in Combination With Ruxolitinib in Myelofibrosis

This is a global, multicenter Phase 1/3 study to evaluate the efficacy and safety of selinexor plus ruxolitinib in JAK inhibitor (JAKi) treatment-naïve myelofibrosis (MF) participants. The study will be conducted in two phases: Phase 1 (open-label) and Phase 3 (double-blind). Phase 1 (enrollment completed) was an open-label evaluation of …

18 - 100 years of age Both Phase 3
F Francesco C Albano

AML Patients Bearing FLT3 Mutations Based on Peripheral Blast Clearance

Prospective, multi-center, interventional, randomized, open clinical trial for the treatment of acute myeloid leukemia with FLT3 mutations customized upon the prognostic parameter PBC

18 - 65 years of age Both Phase 3
F Flavia Salvi, MD

Italian Network MDS Registry

Epidemiological data collection of adult patients affected by myelodysplastic syndrome (MDS) newly diagnosed.

18 - 106 years of age Both Phase N/A
B Boston Scientific Clinical Research

Patient Retrospective Outcomes (PRO)

This study will evaluate de-identified (anonymous) data in subject medical charts to review the clinical outcomes of various treatment approaches in the treatment of chronic pain.

18 - 100 years of age Both Phase N/A

Rewrite in simple language using AI